loading page

MUCOPOLYSACCHARIDOSIS TYPE VI (MAROTEAUX-LAMY SYNDROME) - A CASE IN PERU
  • Jenny Cortez Miranda,
  • Lincoln Blacido Trujillo,
  • Maria Liendo Chocano
Jenny Cortez Miranda
Hospital Militar Central
Author Profile
Lincoln Blacido Trujillo
Hospital Militar Central
Author Profile
Maria Liendo Chocano
Hospital Militar Central
Author Profile

Abstract

A patient with mucopolysaccharidosis type VI, on enzyme replacement therapy (galsulfase) for more than 6-years with good adherence. Urine glycosaminoglycans became stable, cardiopulmonary progression is slow, motor skills have improved, pain is controlled and no adverse reactions were reported. These support the benefits of galsulfase, as it slows disease progression.

Peer review status:IN REVISION

29 Apr 2020Submitted to Clinical Case Reports
06 May 2020Submission Checks Completed
06 May 2020Assigned to Editor
09 May 2020Reviewer(s) Assigned
08 Jun 2020Review(s) Completed, Editorial Evaluation Pending
09 Jul 20201st Revision Received
23 Aug 2020Submission Checks Completed
23 Aug 2020Assigned to Editor
23 Aug 2020Review(s) Completed, Editorial Evaluation Pending
14 Sep 20202nd Revision Received
21 Sep 2020Assigned to Editor
21 Sep 2020Review(s) Completed, Editorial Evaluation Pending
21 Sep 2020Submission Checks Completed